Regeneron (REGN) Withdraws sBLA for Libtayo in Cervical Most cancers
This tale initially seemed on Zacks Regeneron Prescription drugs, Inc. REGN, together with spouse Sanofi SNY, introduced that they’ve voluntarily withdrawn the supplemental biologics license software (sBLA) for PD-1 inhibitor,…